Synthesis of triazolotriazine derivatives as c-Met inhibitors

被引：6

作者：

Guo, Yuting ^{[1
,3
]}

Peng, Xia ^{[2
]}

Ji, Yinchun ^{[2
]}

Zhang, Yitong ^{[2
,3
]}

Ding, Jian ^{[2
,3
]}

Zhan, Zhengsheng ^{[1
]}

Ai, Jing ^{[2
,3
]}

Duan, Wenhu ^{[1
,3
]}

机构：

[1] Chinese Acad Sci, Shanghai Inst Mat Med, Dept Med Chem, 555 Zu Chong Zhi Rd, Shanghai 201203, Peoples R China

[2] Chinese Acad Sci, Shanghai Inst Mat Med, Div Antitumor Pharmacol, State Key Lab Drug Res, 555 Zu Chong Zhi Rd, Shanghai 201203, Peoples R China

[3] Univ Chinese Acad Sci, 19A Yuquan Rd, Beijing 100049, Peoples R China

来源：

MOLECULAR DIVERSITY | 2021年 / 25卷 / 02期

基金：

中国国家自然科学基金;

关键词：

Receptor tyrosine kinase; c-Met; Triazolotriazine; SAR; Cellular potency; GROWTH-FACTOR RECEPTOR; KINASE INHIBITOR; HIGHLY POTENT; DISCOVERY; IDENTIFICATION; PROTOONCOGENE; CABOZANTINIB; METASTASIS; VOLITINIB; PATHWAY;

D O I：

10.1007/s11030-020-10067-5

中图分类号：

Q5 [生物化学]; Q7 [分子生物学];

学科分类号：

071010 ; 081704 ;

摘要：

Receptor tyrosine kinase c-Met is an important antitumor drug target. Triazolotriazine analogues2-10were prepared efficiently and evaluated the enzymatic and cellular c-Met activities. Brief structure-activity relationships of triazolotriazine core and CF2-quinoline part were investigated, leading to the discovery of compound8with nanomolar enzymatic c-Met activity, and subnanomolar MKN45 and EBC-1 cellular potencies. The proposed binding model of 8 and c-Met unraveled that two canonical hydrogen bonds and a pi-pi stacking interaction formed between the inhibitor and the ATP binding site of c-Met kinase domain, which accounted for its potent c-Met activities. [GRAPHICS] .

引用

页码：839 / 846

页数：8

共 50 条

[21] Design, synthesis and pharmacological evaluation of novel thiazole derivatives as c-Met kinase inhibitors and anticancer agents
Gediya, Piyush
Tulsian, Kartik
Vyas, Vivek K.
Dhameliya, Tejas M.
Parikh, Palak K.
Ghate, Manjunath D.
JOURNAL OF MOLECULAR STRUCTURE, 2024, 1317
[22] Discovery of imidazopyridine derivatives as novel c-Met kinase inhibitors: Synthesis, SAR study, and biological activity
Yang, Yifei
Zhang, Yuan
Yang, LingYun
Zhao, Leilei
Si, Lianghui
Zhang, Huibin
Liu, Qingsong
Zhou, Jinpei
BIOORGANIC CHEMISTRY, 2017, 70 : 126 - 132
[23] Fused bicyclic derivatives of 2,4-diaminopyrimidine as c-Met inhibitors
Weinberg, Linda R.
Albom, Mark S.
Angeles, Thelma S.
Husten, Jean
Lisko, Joseph G.
McHugh, Robert J.
Milkiewicz, Karen L.
Murthy, Seetha
Ott, Gregory R.
Theroff, Jay P.
Tripathy, Rabindranath
Underiner, Ted L.
Zificsak, Craig A.
Dorsey, Bruce D.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2011, 21 (01) : 164 - 167
[24] Anthraquinone Derivatives as Potent Inhibitors of c-Met Kinase and the Extracellular Signaling Pathway
Liang, Zhongjie
Ai, Jing
Ding, Xiao
Peng, Xia
Zhang, Dengyou
Zhang, Ruihan
Wang, Ying
Liu, Fang
Zheng, Mingyue
Jiang, Hualiang
Liu, Hong
Geng, Meiyu
Luo, Cheng
ACS MEDICINAL CHEMISTRY LETTERS, 2013, 4 (04): : 408 - 413
[25] Dynasore potentiates c-Met inhibitors against hepatocellular carcinoma through destabilizing c-Met
Zaky, Mohamed Y.
Liu, Xiuxiu
Wang, Taishu
Wang, Shanshan
Liu, Fang
Wang, Duchuang
Wu, Yueguang
Zhang, Yang
Guo, Dong
Sun, Qianhui
Li, Qiong
Zhang, Jinrui
Zhang, Yingqiu
Dong, Weijie
Liu, Zhenhua
Liu, Shuyan
Liu, Han
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, 2020, 680
[26] c-Met abnormatities in patients with genitourinary (GU) malignancies and outcomes with c-MET inhibitors.
Jardim, Denis Leonardo Fontes
Gagliato, Debora De Melo
Falchook, Gerald Steven
Wheler, Jennifer J.
Zinner, Ralph
Janku, Filip
Subbiah, Vivek
Piha-Paul, Sarina Anne
Fu, Siqing
Tannir, Nizar M.
Corn, Paul Gettys
Tang, Chad
Hess, Kenneth R.
Roy-Chowdhuri, Sinchita
Kurzrock, Razelle
Meric-Bernstam, Funda
Hong, David S.
JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (04)
[27] Design, Synthesis, and Biological Evaluation of Novel 2-Amino-4-phenylthiazole Derivatives as c-Met Inhibitors
Zhang, Zhihua
Chen, Yu
Wu, Hongmei
Cui, Bo
Xiong, Wulin
Lin, Tenghui
Lin, Rongnan
Yu, Guo
CHINESE JOURNAL OF ORGANIC CHEMISTRY, 2018, 38 (10) : 2648 - 2656
[28] Molecular modeling studies and synthesis of novel quinoxaline derivatives with potential anticancer activity as inhibitors of c-Met kinase
Abbas, Hebat-Allah S.
Al-Marhabi, Aisha R.
Eissa, Sally I.
Ammar, Yousry A.
BIOORGANIC & MEDICINAL CHEMISTRY, 2015, 23 (20) : 6560 - 6572
[29] Synthesis and bioevaluation study of novel N-methylpicolinamide and thienopyrimidine derivatives as selectivity c-Met kinase inhibitors
Wang, Linxiao
Xu, Shan
Chen, Xiuying
Liu, Xiaobo
Duan, Yongli
Kong, Dejia
Zhao, Dandan
Zheng, Pengwu
Tang, Qidong
Zhu, Wufu
BIOORGANIC & MEDICINAL CHEMISTRY, 2018, 26 (01) : 245 - 256
[30] c-MET Inhibitors in the Treatment of Lung Cancer
Gozdzik-Spychalska, Joanna
Szyszka-Barth, Katarzyna
Spychalski, Lukasz
Ramlau, Katarzyna
Wojtowicz, Jerzy
Batura-Gabryel, Halina
Ramlau, Rodryg
CURRENT TREATMENT OPTIONS IN ONCOLOGY, 2014, 15 (04) : 670 - 682

← 1 2 3 4 5 →